Ou-Yang LY - Search Results

1

Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T_3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy.

Chen S, Ou-Yang LY, Nie RC, Li YF, Xiang J, Zhou ZW, Chen YB, Peng JS. Chen S, et al. Among authors: ou yang ly. Gastroenterol Res Pract. 2017;2017:4928736. doi: 10.1155/2017/4928736. Epub 2017 Feb 26. Gastroenterol Res Pract. 2017. PMID: 28331491 Free PMC article.

2

Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer.

Chen S, Nie RC, OuYang LY, Li YF, Xiang J, Zhou ZW, Chen Y, Peng JS. Chen S, et al. Oncotarget. 2017 Feb 14;8(7):11380-11388. doi: 10.18632/oncotarget.14535. Oncotarget. 2017. PMID: 28077786 Free PMC article.

3

Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination.

Chen S, Nie RC, OuYang LY, Li YF, Xiang J, Zhou ZW, Chen Y, Peng J. Chen S, et al. World J Surg Oncol. 2017 Feb 23;15(1):52. doi: 10.1186/s12957-016-1076-1. World J Surg Oncol. 2017. PMID: 28228146 Free PMC article.

4

A nomogram to predict prognosis for gastric cancer with peritoneal dissemination.

Chen S, Chen X, Nie R, Ou Yang L, Liu A, Li Y, Zhou Z, Chen Y, Peng J. Chen S, et al. Chin J Cancer Res. 2018 Aug;30(4):449-459. doi: 10.21147/j.issn.1000-9604.2018.04.08. Chin J Cancer Res. 2018. PMID: 30210225 Free PMC article.

5

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma.

OuYang LY, Deng ZJ, You YF, Fang JM, Chen XJ, Liu JJ, Li XZ, Lian L, Chen S. OuYang LY, et al. Front Immunol. 2022 Aug 16;13:977894. doi: 10.3389/fimmu.2022.977894. eCollection 2022. Front Immunol. 2022. PMID: 36052090 Free PMC article.

6

Anastomotic leakage and postoperative mortality in patients after esophageal cancer resection.

Su Q, Yin C, Liao W, Yang H, Ouyang L, Yang R, Ma G. Su Q, et al. J Int Med Res. 2021 Sep;49(9):3000605211045540. doi: 10.1177/03000605211045540. J Int Med Res. 2021. PMID: 34590915 Free PMC article.

7

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.

OuYang LY, Wu XJ, Ye SB, Zhang RX, Li ZL, Liao W, Pan ZZ, Zheng LM, Zhang XS, Wang Z, Li Q, Ma G, Li J. OuYang LY, et al. J Transl Med. 2015 Feb 1;13:47. doi: 10.1186/s12967-015-0410-7. J Transl Med. 2015. PMID: 25638150 Free PMC article.

8

Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.

Zhang H, Li ZL, Ye SB, Ouyang LY, Chen YS, He J, Huang HQ, Zeng YX, Zhang XS, Li J. Zhang H, et al. Cancer Immunol Immunother. 2015 Dec;64(12):1587-99. doi: 10.1007/s00262-015-1765-6. Epub 2015 Oct 23. Cancer Immunol Immunother. 2015. PMID: 26497849 Free PMC article.

9

Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study.

Gan YX, Yang ZL, Pan YX, Ou-Yang LY, Tang YH, Zhang YJ, Chen MS, Xu L. Gan YX, et al. Among authors: ou yang ly. Int J Surg. 2024 May 1;110(5):2832-2844. doi: 10.1097/JS9.0000000000001156. Int J Surg. 2024. PMID: 38363991 Free PMC article.

10

Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment.

He M, Chen X, Luo M, Ouyang L, Xie L, Huang Z, Liu A. He M, et al. Clin Exp Immunol. 2020 Oct;202(1):47-59. doi: 10.1111/cei.13476. Epub 2020 Jun 30. Clin Exp Immunol. 2020. PMID: 32516488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters